Skip to main content
finq
OS
Search ticker, company, or fund...
⌘
K
Capture
Closed
UTHR: United Therapeutics Corporation Stock Analysis | finqOS
Healthcare · Biotechnology
The Story
UTHR
The Story
UTHR
Loading chart data...
Current State
Balance holding
The verdict
Good business
Strong
Revenue growth
+23.6% / yr
Operating margin
45.3%
ROIC
18.8%
Financially safe
Strong
Debt / equity
0.00×
Interest coverage
87.6×
Current ratio
4.79×
Valuation
Unrated
P/E ratio
17.7×
United Therapeutics Corporation
UTHR
NASDAQ Global Select
·
USD
·
Closed
Story
Data
Canvas
Capture
Save
United Therapeutics Corporation
UTHR
NASDAQ
·
USD
·
Closed
$517.71
−1.54%
$517.71
−$8.11 (1.54%)
52W Range
72th
pctl
Volume
0.82×
avg
Mkt Cap
21.98B
USD
P/E
17.7
TTM
Div Yield
–
ann
52W Range
72th
pctl
Volume
0.82×
avg
Market Cap
21.98B
USD
P/E Ratio
17.7
TTM
Div Yield
-
ann
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings
Overview
Financials
Peers
Sentiment
Analysis
Transcripts
Holders
Company
SEC Filings